Role of macrophage secretions on rat polycystic ovary: Its effect on apoptosis by Figueroa, Maria Florencia et al.
1 
 
Role of macrophage secretions on rat polycystic ovary: Its effect on apoptosis. 1 
Florencia Figueroa
1
, Alicia Motta
2
, Mariano Acosta
3
, Fabian Mohamed
3
,
 
Liliana Oliveros
1 
and 2 
Myriam Forneris
1*
 3 
1
Laboratorio de Biología de la Reproducción y 
3
Area Morfología, Departamento de Bioquímica y 4 
Ciencias Biológicas, Facultad de Química, Bioquímica y Farmacia, Universidad Nacional de San 5 
Luis, and IMIBIO-San Luis, CONICET, Argentina. 6 
2
Laboratorio de Fisio-patología Ovárica (CEFYBO), Universidad de Buenos Aires, Argentina. 7 
 8 
Short running title: macrophages on polycystic ovarian apoptosis 9 
 10 
Mailing address of corresponding author 11 
*Dra. Myriam Forneris 12 
Laboratorio de Biología de la Reproducción 13 
Facultad de Química, Bioquímica y Farmacia 14 
Universidad Nacional de San Luis, Avenida Ejército de los Andes 954, 5700 San Luis, Argentina. 15 
Tel. + 54 266 4520300 int 1617 16 
Email address: mlforneris@gmail.com 17 
 18 
Key words: polycystic ovary, macrophages, apoptosis, prostaglandin E2, androgens 19 
 20 
 21 
 22 
 23 
 24 
Page 1 of 42
 Reproduction Advance Publication first posted on 11 August 2015 as Manuscript REP-15-0216
 Copyright © 2015 by the Society for Reproduction and Fertility.
2 
 
Abstract  25 
Polycystic ovarian syndrome is the most common endocrine disorders among women of 26 
reproductive age. Little is known about its etiology, although the evidence suggests an intrinsic 27 
ovarian abnormality in which endocrine, metabolic, neural and immune factors would be involved. 28 
In this work, the effects of macrophage (MO) secretion on ovarian apoptosis in a polycystic ovary 29 
syndrome rat model (PCO rat) induced by estradiol valerate are studied. Spleen macrophages 30 
secretions were used to stimulate ovaries, and ovarian interstitial and granulosa cells, from both 31 
PCO and control rats. Ovarian hormones and prostaglandin E2 (PGE2) were measured by 32 
radioimmunoassay; ovarian mRNA levels of Bax, Bcl2 and NFkB by RT-PCR; and ovarian 33 
inducible nitric oxide synthase (iNOS) by western blot. The number of apoptotic cells was evaluated 34 
by TUNEL. In PCO ovary, the MO secretions from PCO rats increased the Bax and NFkB mRNA 35 
expressions, and increased TUNEL staining in both granulosa and theca cells. In addition, the PCO 36 
MO secretions produced a decrease of nitric oxide release, iNOS protein level and PGE2 content in 37 
the PCO ovary, and it also induced an increase of androstenedione production by PCO interstitial 38 
cells, in comparison with control MO secretions. Considering these results and knowing that 39 
testosterone stimulates tumour necrosis factor-α production by PCO MO, modifying ovarian 40 
response by increasing androstenedione, it is reasonable to suggest that the increase of androgens 41 
stimulated in ovarian cells by PCO MO secretions could in turn stimulate the cytokine production 42 
from MO, thus maintaining an apoptotic vicious cycle in the PCO ovary. 43 
 44 
 45 
Introduction 46 
The bidirectional communication between the neuroendocrine and immune system is firmly 47 
recognized. A number of hormonal and neuropeptide mediators have been shown to influence 48 
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immune development and function in both healthy and diseased individuals (Bilbo & Klein, 2012). 49 
The interactions between ovary and immune cells and the products such as steroids, peptide 50 
hormones, prostaglandins, growth factors and cytokines play a pivotal role in the regulation of 51 
ovarian function (Basedovsky & del Rey 1996, Taub 2008).  52 
The macrophages, the most abundant immune cells within the ovary, have been localized in thecal, 53 
luteal and interstitial tissue compartments and in the atretic follicle, in both animal and human. Their 54 
distribution fluctuates throughout the ovarian cycle with the highest numbers being present at 55 
proestrus and diestrus, strongly indicating hormonal regulation (Wu et al. 2004, 2007, Turner et al. 56 
2011). Macrophages express functional sex hormone receptors and secrete nitric oxide (NO), along 57 
with tumor necrosis factor alpha (TNFα), prostaglandin E2 (PGE2), interleukins (IL)-1, IL6, IL10, 58 
IL12 and many other cytokines and growth factors that regulate ovarian function (Gallinelli et al. 59 
2003, Sirotkin et al. 2011). There is evidence that NO decreases ovarian steroidogenesis by 60 
inhibiting the steroid acute regulatory protein, 3β-hydroxysteroid dehydrogenase (3β-HSD) and 61 
cytochrome p450 side chain cleavage gene expression (Rekawiecki et al. 2005). Furthermore, TNFα 62 
is a multifunctional cytokine that influences the reproductive axis, inducing changes that closely 63 
resemble those found in patients with hyperandrogenism (Thathapudi et al. 2014). TNFα plays a 64 
key role in follicular development and atresia, decreases ovarian cell viability and proliferation, and 65 
stimulates apoptosis in cultured ovarian follicles (Greenfeld et al. 2007). When TNFα binds to its 66 
receptor (TNFR1), caspase-8 and caspase-3 are cleaved and activated, and the induction of IkB 67 
phosphorylation and degradation activate the nuclear factor kB (NFkB). Subsequently, NFkB 68 
translocates into the nucleus where it can activate the transcription of certain genes, particularly 69 
those involved in immune and inflammatory responses (Xiao 2002). In addition, PGE2 modulates a 70 
variety of physiological processes including the production of inflammatory cytokines (Kuroda & 71 
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Yamashita 2003). PGE2 and their receptor subtypes, EP2 and EP4, are involved in the rat ovarian 72 
follicle growth (El-Nefiawy et al. 2005).  73 
It is known that a fine balance between pro- and anti-apoptotic factors may determine whether a 74 
follicle will continue developing or undergo atresia. Regulation of apoptotic signaling in the ovary is 75 
achieved by the Fas system and Bcl2 family, including Bcl2 (antiapoptotic) and Bax (proapoptotic) 76 
proteins. The increased expression of the Bax death susceptibility gene coincides with the induction 77 
of apoptosis in granulosa cells during atresia in vivo and in vitro (Tilly 2001). Several studies 78 
suggest a cross-talk between the Fas/FasL system-induced apoptosis and the nitric oxide-mediated 79 
antiapoptotic pathway in ovarian follicle atresia (Chen et al. 2005, Krysko et al. 2008). Also, its 80 
have been shown that androgen and androgen receptor promote Bax-mediated apoptosis in prostate 81 
cancer cells (Lin et al. 2006). Furthermore, it is known that PGE2 promotes proliferation and 82 
survival of cells through apoptosis inhibition (Sheng et al. 1998, Rask et al. 2006). 83 
Polycystic ovary syndrome (PCOS) is a common endocrine and metabolic disorder in women of 84 
reproductive age, characterized by anovulation, hyperandrogenemia and/or hyperandrogenism, and 85 
frequently, insulin resistance and hyperinsulinemia (Goodarzi et al. 2011). Ovaries from most 86 
women affected by PCOS are characterized by thecal/interstitial hyperplasia and increased 87 
expression of steroidogenic genes, leading to greater androgen biosynthesis and cytochrome 88 
P450c17 alpha gene expression (Nelson-Degrave et al. 2005).  89 
Several studies suggest that the immune regulation may be involved in the etiology of PCOS 90 
(Amato et al. 2003, Niccoli et al. 2011). Furthermore, neuroimmunomodulatory factors such as 91 
dopamine, have been associated to this disorder etiology (Gómez et al. 2011). We have shown a 92 
functional relationship between the ovarian androgens and immune cells in a rat model of PCOS 93 
induced by estradiol valerate (EV). The differential steroidogenic ability of macrophage secretions 94 
from those rats is associated to the in vitro testosterone environment. Testosterone, probably acting 95 
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on macrophage androgen receptor, induces a greater release of TNFα, modifying ovarian response 96 
by increasing androstenedione and slightly decreasing estradiol without affecting progesterone 97 
(Figueroa et al. 2012).  98 
There is evidence that dysfunction of granulosa cells may contribute to abnormal folliculogenesis, 99 
although the underlying mechanism remains to be determined. It has been demonstrated that there 100 
are significant differences in the rate of cell death and proliferation in granulosa cells in PCOS 101 
patients compared to women with regular ovulatory cycles. This was associated with decreased 102 
expression of apoptotic effectors and increased expression of a cell survival factor (Das et al. 2008). 103 
However, the role of immune cells on the apoptosis of polycystic ovary remains obscure. 104 
It is known that the EV-PCO model is characterized by acyclicity, anovulation, hyperandrogenemia 105 
and polycystic ovarian morphology, and is associated with increased sympathetic activity 106 
resembling PCO (Brawer et al. 1986, Lara et al. 1993, Forneris et al. 2003), without metabolic 107 
disturbances such as dyslipidemia, insulin resistance or obesity (Stener-Victorin et al. 2005). 108 
Therefore, the aim of this study is to investigate in a rat model of PCOS induced by EV (PCO rats): 109 
1) whether secretions of macrophages induce apoptosis in the ovary, and 2) if macrophage 110 
secretions modify the ovarian PGE2 and nitric oxide levels, and consequently the androstenedione 111 
response, in order to stablish their relationship with the ovarian apoptosis. For that, secretions of 112 
macrophages from spleen were used to stimulate isolated ovarian cells and ovaries from PCO rats. 113 
  114 
Materials and Methods 115 
Reagents 116 
Estradiol valerate (EV), fetal bovine serum and RPMI 1640 medium were purchased from Sigma 117 
(St. Louis, MO, USA). TRIzol reagent was obtained from Invitrogen/Life Technology. 1,2,6,7-[
3
H]-118 
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Prostaglandin E (107.0 Ci/mmol) was provided by New England Nuclear Products (Boston, MA, 119 
USA). Other reagents and chemicals were of analytical grade.  120 
Animals and treatment 121 
Adult Holtzman cycling rats showing at least two regular 4-day cycles were used. They were housed 122 
in a controlled environment (22–24 °C, 12 h light–12 h dark). Water and food were available ad 123 
libitum. Animals were handled according to the procedures approved in the UFAW Handbook for 124 
the Care and Management of Laboratory Animals - vol 1- Terrestrial vertebrates-edn 7, edited by T 125 
Poole (1999), and the experimental protocol was approved by the Committee for the Use and Care 126 
of Animals of the National University of San Luis.  127 
Two groups of rats were used. The first group consisted in PCO rats to which the PCOS model was 128 
induced at 60 days of age. This was accomplished by the administration of EV as a single 129 
intramuscular injection (2 mg/rat diluted in 0.2 ml corn oil) in order to resemble, in some aspects, 130 
the human syndrome (Brawer 1986). The second group, non-PCO rats (control rats), was injected 131 
with vehicle alone. All experiments were performed two months after EV injection, at which point 132 
cystic follicles were observed by light microscopy. Cystic follicles were devoid of oocytes and 133 
exhibited a large antral cavity, an enlarged thecal cell layer, and a thin granulose-cell compartment. 134 
Since PCO rats predominantly showed cornified vaginal smears, control rats were sacrificed by 135 
decapitation on estrus day. The spleen and the ovaries were removed to obtain macrophages (MO) 136 
for culture and ovarian incubations, respectively. 137 
Macrophage culture  138 
The culture of MO was performed as described previously (Figueroa et al. 2012). Briefly, the 139 
spleens from PCO and control rats were washed in saline solution and pressed through a sterile 140 
nylon screen (200-µm mesh) to obtain the total cell populations. After centrifugation, the cells were 141 
resuspended in serum-free RPMI 1640 medium and treated with NH4Cl. Cell number and viability 142 
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were assessed microscopically using trypan blue exclusion. 3×10
6
 viable cells/ml of medium were 143 
incubated in culture medium supplemented with 10% (v/v) heat inactivated fetal bovine serum 144 
(FBS) and antibiotics (50 µg/ml streptomycin and 50 units/ml penicillin), defined as basal medium, 145 
in culture plates. After incubation for 2 h at 37 °C in 95% air-5% CO2, the non-adhered cells were 146 
removed. The adhered MO monolayer showed 90% purity according to the morphologic analysis 147 
performed by Giemsa staining (Supplementary Figure 1, see section on supplementary data given at 148 
the end of this article) and nonspecific esterase staining. The MO from PCO rats (PCO MO), as well 149 
as the MO from control rats (control MO), were plated at a density of 1×10
6
 cells/well in a final 150 
volume of 1 ml in culture plates, preincubated in basal medium for 24 h and subsequently cultured 151 
for 24 h. The respective culture media were collected and used to stimulate ovaries and isolated 152 
ovarian cells from PCO rats (PCO ovaries), as well as from control rats (control ovaries). 153 
Ovary incubation  154 
After sacrificing the rats, the ovaries from PCO and control rats were halved and preincubated in 1 155 
ml of basal medium at 37 °C, in a 95% O2–5% CO2 mixture. After 15 min, the incubation media 156 
were discarded and either 1 ml of basal medium or 1ml of MO secretions (PCO MO or control MO 157 
culture medium, respectively) was added (Forneris et al. 2008). Incubation was continued for 3 h, 158 
and then the medium was removed and stored at -20 °C until measurement of PGE2 and nitrites 159 
release contents.  160 
Obtaining and incubation of ovarian cells 161 
The procedures for harvesting and culturing the granulose cells have been described previously 162 
(Erickson & Hsueh 1978, Aguado & Ojeda 1984). Briefly, granulosa cells from ovaries of PCO and 163 
control rats were harvested in RPMI 1640 medium, supplemented with 0.2% bovine serum albumin 164 
(BSA) fraction V, N-2-hydroxyethylpiperazine-N’-2-ethanesulfonic acid (HEPES) (10 mM) and 165 
ethylene glycol tetraacetic acid  (EGTA) (6.8 mM), by needle-puncturing of the follicles. The 166 
Page 7 of 42
8 
 
suspension was centrifuged at 100 x g for 10 min, and the cell pellet was washed in RPMI medium 167 
containing penicillin (50 U/ml) and streptomycin (50 µg/ml). After viability determination by trypan 168 
blue exclusion test, the cells were plated at 3x10
5
 viable cells/tube containing 1 ml of RPMI 1640 169 
medium supplemented with androstenedione (10
-7
 M), L-glutamine (2 mM), penicillin (50U/ml), 170 
streptomycin (50 µg/ml) and ovine FSH (10 ng/ml). Androstenedione was included in all cultures 171 
and served as aromatase substrate (Erickson & Hsueh 1978). The cells were cultured in a humidified 172 
95% v/v air and 5% v/v CO2 incubator at 37 °C for 24 h. At the end of this period, the medium was 173 
discarded and replaced by fresh medium with antibiotics or macrophages secretions. The incubation 174 
was continued for 24 h and then the medium was stored at -20 °C until assayed for estradiol release. 175 
After harvesting granulosa cells by needle-puncturing of the follicles, the corpora lutea were 176 
removed, and the residual ovarian tissue, which is considered to be enriched in interstitial cells, was 177 
dissociated in 2 ml of RPMI medium containing 0.4% w/v collagenase type XI (Sigma-Aldrich Co.) 178 
and 0.1% BSA fraction V (Sigma-Aldrich Co.), by stirring at 37
o
C for 30 min in a metabolic 179 
shaking water bath and assisted by repeatedly drawing tissue fragments into a siliconized pipette. 180 
Five minutes before finishing the procedure, 0.001% of deoxyribonuclease type I (DNase I) (Sigma 181 
Inc, USA) was added. Subsequently, the digest was filtered through a nylon mesh and the 182 
suspension was centrifuged at 100 x g for 10 min. The cell pellet was washed twice in RPMI 183 
medium containing penicillin (50 U/ml) and streptomycin (50 µg/ml), centrifuged as described 184 
above, and finally resuspended in the same medium. 5 x 10
5
 cells were cultured in a humidified 95% 185 
v/v air and 5% v/v CO2 incubator at 37 °C for 24 h. At the end of this period, the medium was 186 
removed, replaced by fresh medium with antibiotics or MO secretions, and the cells were cultured 187 
for an additional 24 h. Afterwards, the culture medium was stored at -20 °C until assayed for 188 
androstenedione release.  189 
Steroid assays 190 
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Estradiol and androstenedione released in the media from the culture of granulosa and interstitial 191 
cells, respectively, were determined by RIA using specific antisera as described previously (Forneris 192 
& Aguado 2002). The assays sensitivities were less than 12 fmole/tube for estradiol and 0.02 ng/ml 193 
for androstenedione. For all steroids, the inter- and intra-assay coefficients of variation were less 194 
than 10%. 195 
Nitrite assay 196 
Liquid incubations of ovaries from control and PCO rats were removed and analyzed for NO by 197 
assaying nitrites, which is a stable product of NO oxidation, using the Griess reagent; the absorbance 198 
was read at 540 nm (Egami & Taniguchi 1974). The intra-assay coefficients of variation were less 199 
than 10%. The results were expressed as micromoles of nitrite per milliliter (µmol/ml). 200 
Histological studies  201 
After incubation with basal medium or MO secretions, the ovaries were fixed in Bouin’s solution. 202 
The samples were dehydrated in graded series of ethanol and embedded in paraffin. Sections of 5 203 
µm in thickness were obtained using a Microm HM 325 rotation microtome and stained with 204 
hematoxylin-eosin. Histological analysis was carried out using a computer-assisted image analysis 205 
system consisting of an Olympus BX-40 binocular microscope. The images were captured by a 206 
Sony SSC-DC5OA camera and processed with Image Pro Plus 5.0 software under control of a 207 
Pentium IV computer. 208 
Identification of apoptotic nuclei by TUNEL assay 209 
Apoptotic nuclei were identified in ovarian tissue using the DeadEnd ™Colorimetric TUNEL 210 
System (Promega, Madison, USA) according to the manufacturer’s protocol. Briefly, nuclear DNA 211 
fragmentation was assessed in 5 µm thick sections of ovarian tissue mounted on silane-coated slides, 212 
deparaffinized with xylene and then treated with a graded series of ethanol [100%, 95%, 85%, 70%, 213 
and 50% (v/v)] and rehydrated in PBS (pH 7.5). Tissues were then treated with proteinase K 214 
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solution for permeabilization and then refixed with 4% paraformaldehyde solution. Slides were then 215 
treated with recombinant terminal deoxynucleotidyl transferase (TdT) reaction mix and incubated in 216 
a humidified chamber at 37 °C for 1 h. The reaction was terminated by immersing the slides in 2 × 217 
SSC solution (saline-sodium citrate) for 15 min at room temperature. After blocking the endogenous 218 
peroxidases activity (by 0.3% hydrogen peroxide), slides were washed with PBS and then incubated 219 
with streptavidin horseradish peroxidase solution for 30 min at room temperature. Afterwards, the 220 
slides were incubated for 10 min with 3,3′-diaminobenzidine (DAB) as chromogen substrate. The 221 
sections were counterstained with hematoxylin, dehydrated, mounted and coverslipped. For negative 222 
control, incubation with TdT was omitted and the positive control was prepared by treating cells on 223 
a separate slide with DNase I. Cells showing dark brown staining from the colorimetric reaction 224 
were considered as positive for DNA fragmentation. 225 
The results of the TUNEL assay were evaluated according to the signal intensity as negative (–) and 226 
positive (+).  TUNEL positive staining was examined in 10 consecutive areas from 5 independent 227 
ovarian sections. A total of 50 fields, from control and treated groups, were analysed. The number of 228 
TUNEL-positive follicles with apoptotic cells was counted in independent ovarian cross sections 229 
from three different rats under microscope at x100 objective. 230 
Western blot analysis for iNOS 231 
Ovaries were homogenized in tris-HCL 50nM (pH 7.8) containing protease inhibitors. Protein was 232 
measured by the method of Lowry et al. (1951). 40 mg of proteins were mixed with 10 ml of sample 233 
buffer (125 mM Tris-HCl, pH 6.8, 4% SDS, 0.5 mM DTT, 0.02% bromophenol blue and 20% 234 
glycerol), boiled for 2–3 min and loaded into 8% SDS-PAGE gel. Protein molecular mass markers 235 
were always loaded on each gel. The separated proteins were transferred to PVDF membranes 236 
(Polyscreen NEF 1000 purchased from NEN Life Science Products) using a blot transfer system 237 
(BioRad Laboratories, Hercules, CA). After being blocked overnight with 5% BSA-TBS solution 238 
Page 10 of 42
11 
 
(20 mM Tris, 500 mM NaCl, pH 7.5) at 48 
o
C, membranes were incubated with a primary rabbit anti 239 
iNOS polyclonal antibody solution (Santa Cruz Biotechnology) (1:1000 dilution), for 1 h at room 240 
temperature. β-actin expression was measured as a control for protein loading using a rabbit 241 
polyclonal antibody. After washing three times with TTBS (0.1% Tween 20, 100 mM Tris-HCl, pH 242 
7.5, 150 mM NaCl), the membranes were incubated with an anti-rabbit IgG secondary antibody 243 
linked to peroxidase for 1 h at room temperature. The membranes were washed and the colour was 244 
developed using a Vectastain ABC detection system.  245 
Prostaglandin E2 radioimmunoassay  246 
PGE2 was determined by radioimmunoassay (RIA) as it has been previously reported (Motta et 247 
al.1999). PGE2 was quantified in incubation medium from ovary, and in ovary homogenate from 248 
PCO and control rats. To extract PGE2, the samples were first acidified to pH 3.0 with 1 M HCl and 249 
then extracted three times with 1 ml of ethyl acetate. The ethyl acetate extracts were dried under an 250 
atmosphere of N2 and stored at -20°C until prostaglandin RIA was performed. PGE2 was quantified 251 
by using rabbit antiserum from Sigma Chemical Co (St. Louis, USA). The sensitivity was 10 252 
pg/tube and the cross-reactivity was 100% PGE2 and < 0.1% with other prostaglandins. Results are 253 
expressed as pg/mg of tissue or ml of medium.   254 
RNA extraction and semiquantitative RT-PCR  255 
Total RNA was extracted from MO culture using TRIzol reagent. The semi-quantitative analysis of 256 
mRNA, was performed using a one-step RT-PCR method (Access RT-PCR system, Promega, 257 
Madison, USA). All components for RT and PCR were assembled in 50 µl reactions containing 5x 258 
reaction buffer (10 mM Tris–HCl, pH 8.3, 50 mM KCl), 3 mM MgCl2, 10 mM dNTP mixture, 1 µM 259 
of each gene specific primers, 2 µg template RNA, 5 units of AMV reverse transcriptase and 5 units 260 
of Tfl DNA polymerase. The amplification of cDNA was performed under the following conditions: 261 
denaturation at 94 °C for 2 min followed by 35 cycles of denaturation at 94 °C for 30 s; annealing at 262 
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60 °C for Bcl2, NFkB and GAPDH, and at 61 °C for Bax, during 1 min; and extension at 72 °C for 263 
2 min. The reaction was completed with a final extension at 72 °C for 7 min (thermal cycler). The 264 
following primers were used: Bax: (5′-GCGAATTGGAGATGAACTGG -3′ sense, and 5′-265 
GTGAGCGAGGCGGTGAGGAC-3′ anti-sense), Bcl2 (5′-GCAACCGAACGCCCGCTGTG -3′ 266 
sense and 5′-GTGATGCAGGCCCCCACCAG-3′ antisense), NFkB: (5′-267 
AGCCCAGAAATATGGACCGT-3′ sense and 5′-TCGAAATCTGAAGCCTCGCTGT-3′ 268 
antisense), GAPDH: (5′-GGGCTGCCTTCTCTTGTGAC-3′ sense and 5′-269 
CGCCAGTAGACTCCACGACA-3′ antisense). The predicted sizes of the PCR-amplified products 270 
were 366, 474, 180, and 325 base pairs (bp) for Bax, Bcl2, NFkB and GAPDH, respectively. The 271 
PCR products were resolved on 2% agarose gel electrophoresis, containing 0.5 mg/ml GelRed, and 272 
photographed with a Polaroid camera. Band intensities of RT-PCR products were quantified using 273 
NIH Image software. The relative abundance of each band was normalized according to the 274 
housekeeping GAPDH gene, calculated as the ratio of the intensity values of each product to that of 275 
GAPDH. Thus, results are expressed as mRNA/GAPDH in arbitrary units. 276 
Statistical analysis  277 
All data shown are expressed as mean ±S.E.M. and analyzed using GraphPad Prism 5. Significant 278 
differences among means were considered at a level of P<0.05 and identified by one-way ANOVA 279 
and Tukey’s test.  280 
 281 
Results 282 
Macrophage secretions action on the ovarian Bax, Bcl2 and NFkB mRNA expressions 283 
Presented in Fig. 1A are the results of the densitometric analysis of Bax mRNA (an apoptosis 284 
promoter) corrected for GADPH expression (relative densitometric units), in PCO and control 285 
ovaries incubated with basal medium (basal conditions), control MO secretions and PCO MO 286 
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secretions. It is observed that in basal conditions, the Bax mRNA expression of the PCO ovary was 287 
not significantly different to that of the control ovary. Incubating control ovaries with either control 288 
or PCO MO secretions resulted in a similar Bax mRNA expression in relation to the control ovary in 289 
basal conditions. Furthermore, incubation of PCO ovary with control MO secretions did not show 290 
significant variations in the Bax mRNA expression with respect to PCO ovary in basal conditions. 291 
However, incubation of the PCO ovary with PCO MO secretions presented a significant increase of 292 
Bax mRNA expression with respect to PCO ovary incubated in basal conditions (P<0.01), and 293 
therefore also showing a significant increase compared to the respective control ovary (P<0.001).  294 
As shown in Fig 1B, no differences in the Bcl2 (an apoptosis inhibitor) mRNA expression were 295 
observed between PCO and control ovaries incubated with either basal medium, PCO  296 
MO secretions or control MO secretions. From the data shown in Fig. 1A and 1B, it can be 297 
concluded that incubation of PCO ovaries with PCO MO secretions, leads to an increase of the Bax 298 
to Bcl2 ratio with respect to PCO ovaries incubated in basal conditions (1.49 ± 0.06 vs 1.16 ± 0.03; 299 
P<0.05), and also respect to the control ovaries incubated with PCO MO secretions (1.49 ± 0.06 vs 300 
0.97 ± 0.03; P<0.05).  301 
Incubation of PCO ovaries in basal medium shows no significant differences in the NFkB mRNA 302 
expression compared to the corresponding control ovaries. Furthermore, after incubating with both 303 
control and PCO MO secretions, no variations were observed in the NFkB mRNA expression of the 304 
control ovaries compared to the control ovary in basal conditions. However,  PCO ovaries incubated 305 
with both control and PCO MO secretions, presented an increase of the NFkB gene expression 306 
compare to PCO ovaries incubated in basal conditions (P<0.05 and P<0.01, respectively). Likewise, 307 
there was also an increase of the gene expression with respect to the corresponding control ovaries 308 
incubated with both control and PCO MO secretions, being this increase greater when PCO ovaries 309 
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were incubated with PCO MO secretions (P<0.05 for control and P<0.01 for PCO MO secretions) 310 
(Fig. 1C).   311 
Macrophage secretions on the ovarian PGE2 content and release 312 
Presented in Fig. 2A are the results of the PGE2 content in the ovaries. It is observed that under basal 313 
conditions, the PGE2 content was significantly increased in the PCO ovary respect to the control 314 
ovary (P<0.001). It is also observed that incubating the control ovaries with both control and PCO 315 
MO secretions, does not show an appreciable variation of prostaglandin content with respect to 316 
ovaries incubated in basal conditions. However, incubation of the PCO ovary with both control and 317 
PCO MO secretions showed a significant decrease of PGE2 content with respect to PCO ovary in 318 
basal conditions, and also compared to their respective control ovaries (P<0.001), being this 319 
decrease more pronounced in the case of PCO ovary incubated with PCO MO secretions. 320 
As shown in Fig. 2B, under basal conditions, the amount of PGE2 released from the PCO ovary was 321 
significantly increased compared to the control ovary (P<0.001). Incubating the control ovaries with 322 
both control and PCO MO secretions, resulted in no significant variation in the amount of PGE2 323 
released with respect to control ovaries incubated with basal medium. However, incubation of the 324 
PCO ovary with both control and PCO MO secretions showed a significant decrease of PGE2 release 325 
with respect to PCO ovary in basal conditions (P<0.001), being this decrease more pronounced in 326 
the case of PCO ovary incubated with PCO MO secretions. Therefore, incubating the PCO ovary 327 
with PCO MO secretions showed a decrease of PGE2 release compared to the corresponding control 328 
ovary (P<0.05).  329 
Macrophage secretions on the ovarian nitrite release and iNOS protein expression 330 
Presented in Fig. 3A are the results of nitrite released from the ovaries. The release of nitrites from 331 
PCO ovary incubated in basal conditions showed an increase with respect to the nitrites released by 332 
the corresponding control ovary (P<0.01). Stimulating control ovaries with both control and PCO 333 
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MO secretions, resulted in a similar increase of nitrite release compared to control ovaries in basal 334 
condition (P<0.001). Furthermore, incubation of the PCO ovaries with control MO secretions 335 
showed an increase of nitrites released (P<0.01) with respect to basal conditions, while no change 336 
was observed when incubating with PCO MO secretions. Thus, incubation PCO ovaries with PCO 337 
MO secretions showed a significant decreased of the nitrite released from the PCO ovaries in 338 
relation to the respective control ovary (P<0.001).  339 
Figure 3B shows the results of iNOS protein expression in the ovaries. Immunoblot analysis with an 340 
anti-iNOS monoclonal antiboby demonstrated enhanced levels of iNOS protein expressions in PCO 341 
ovaries incubated in basal conditions relative to the corresponding control ovary (P<0.05). 342 
Stimulation of the control ovaries with both control and PCO MO secretions, did not show changes 343 
of the iNOS expression with respect to that in basal conditions; while stimulating the PCO ovaries 344 
with both secretions resulted in a decrease of the iNOS expression relative to the PCO ovary in basal 345 
conditions (P<0.001), being this decrease more important with PCO MO secretions. Therefore, 346 
incubating the PCO ovary with PCO MO secretions showed a decrease of iNOS protein compared to 347 
the corresponding control ovary (P<0.001). 348 
Effect of macrophage secretions on the steroids release from ovarian cells 349 
Incubating with MO secretions from PCO as well as from control rats had a stimulatory effect on the 350 
androstenedione release from interstitial cells of both control and PCO ovaries, compared to their 351 
respective basal values (P<0.001). In all cases, including basal conditions, PCO ovaries released 352 
more androstenedione than control ovaries (Fig. 4A), being this difference greater when stimulating 353 
with PCO MO secretions. Figure 4B shows that after stimulation with both control and PCO MO 354 
secretions, estradiol release from control granulosa cells showed no significant differences 355 
compared to basal conditions. However, incubating the PCO granulosa cells with both secretions, 356 
resulted in a decrease of the estradiol release relative to the cells in basal conditions, and this 357 
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decrease was more pronounced when PCO granulosa cells were incubating with PCO MO secretions 358 
(P<0.05 for control and P<0.01 for PCO MO secretions). 359 
Effect of macrophage secretions on the ovarian TUNEL staining 360 
In situ TUNEL analysis was used to detect the presence of apoptotic activity in ovarian sections 361 
(Fig. 5A-F). As expected, in basal conditions, the control ovary showed low or no staining, and 362 
absence of cystic follicles. Only a negligible amount of apoptosis in granulosa cells of secondary 363 
and antral follicles was observed (Fig. 5A). On the other hand, the PCO ovary showed TUNEL 364 
positive reaction in few primary follicles, an increased reactivity in secondary and antral follicles, as 365 
well as abundance of cystic follicles, compared to control (Fig. 5B). TUNEL staining was 366 
predominately localized in granulosa cells and in less extent on theca cells. It was observed that 367 
when incubating with PCO MO secretions, the TUNEL reactivity in secondary and antral follicles of 368 
control ovary increased (Fig. 5E), and even more in secondary and antral follicles of PCO ovary 369 
(Fig. 5F), compared with the respective ovary in basal conditions. TUNEL staining was seen in both 370 
granulosa as well as theca cells in PCO ovaries under stimulation with PCO MO secretions. The 371 
distribution of TUNEL positive reactions in granulosa cells in primary, secondary and antral 372 
follicles is illustrated in the Table 1. 373 
 374 
Discussion  375 
 376 
Cystic ovarian disease and/or polycystic ovarian syndrome (PCOS) are reproduction disorders that 377 
affect human beings and other species such as bovine, ovine, caprine and porcine (Garverick 1997, 378 
Jakimiuk et al. 2002, Silvia et al. 2002, Salvetti et al. 2004, Salvetti et al. 2007). The heterogeneity 379 
of the syndrome is reflected in many polycystic ovaries animal models (Mahajan 1988, Salvetti et 380 
al. 2004, Baravalle et al. 2006, Francou et al. 2008). Furthermore, estradiol valerate is one of the 381 
most widely used steroids to induce PCO in rats (Brawer et al. 1986, Rosa et al. 2003). On this 382 
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basis, in the current work, the effect of macrophage secretions on the polycystic ovarian apoptosis 383 
has been studied in order to gain further knowledge on the mechanisms determining PCO. The 384 
results show that macrophage secretions induce apoptosis in the PCO ovary.  385 
In the ovary, the mechanisms underlying decisions of life and death involve cross-dialogue between 386 
pro-apoptotic and pro-survival molecules through fetal and adult life, which are carried out by 387 
several molecular pathways, out of which the Bcl2 family, TNFα and caspases proteins appear to be 388 
important players. The Bax/Bcl2 ratio, which is thought to be a critical determinant of cell fate (a 389 
low ratio favours extended survival of cells, whereas a high ratio accelerates cell death) (Rueda et 390 
al. 1999, Tilly 2001, Skarzynski et al. 2005, Bas et al. 2011), was significantly higher in PCO than 391 
in control ovary incubated with PCO MO secretions, suggesting that these secretions may be 392 
involved in an imbalance among apoptotic and pro-apoptotic family members in the PCO ovary. In 393 
this sense, the NFkB mRNA expression was increased in the PCO ovary after incubation with the 394 
PCO MO secretions. It is known that the activation of this transcription factor, which induces the 395 
transcription of downstream target genes involved in the inflammatory and apoptotic process 396 
(Perkins 2007), is induced by TNFα in rat granulosa cells through phosphorylation of IkB 397 
(Gonzalez-Navarrete et al. 2007). Considering the pro-apoptotic role for TNFα in reproductive 398 
tissues (Kaipia et al. 1996, Hussein 2005, Haider & Knöfler 2009), and having observed that 399 
secretions from spleen MO of PCO rats contain more TNFα than secretions from control MO 400 
(Figueroa et al. 2012), the induction of NFkB mRNA expression in the PCO ovary after incubation 401 
with control MO secretions, which was even more accentuated with PCO MO secretions, could be 402 
associated, at least till some extend, to the TNFα levels of the MO secretions. In addition, after 403 
incubation with PCO MO secretions, an increase of the apoptotic nuclei number in the granulosa 404 
cells of PCO ovary was detected by TUNEL staining. All these findings suggest that PCO MO 405 
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secretions induce apoptosis in the PCO ovary. Furthermore, immune cells play an important role in 406 
the pathology of PCOS, as suggested by the high concentration of white cells in PCO ovary 407 
(Bukulmez & Arici 2000, Wu et al. 2004, 2007). Thus, resident macrophage population could 408 
possibly modulate the cell death in the PCO ovary. 409 
In the ovary, resident macrophage and other white cells, as well as follicular granulosa and theca 410 
cells, are known to produce prostaglandins (Takaya et al. 1997). In particular, PGE2 has been shown 411 
to mediate the ovarian follicle growth in the rat in vivo (El-Nefiawy et al. 2005). In the present 412 
work, it was found that the content of PGE2 in the PCO ovary incubated with basal medium was 413 
higher than in control ovary, as it was also observed with the PGE2 release. This agrees with results 414 
from other authors who found an increased PGE2 release from dehydroepiandrosterone- or letrozole- 415 
induced polycystic ovaries in rats, and also from polycystic ovary granulosa cells collected from 416 
women (Navarra et al. 1996, Jabbour et al. 2009, Rezvanfar et al. 2011). Interestingly, both control 417 
and PCO MO secretions decreased the PGE2 content of PCO ovary, and this decrease was more 418 
pronounced with PCO than with control MO secretions. It is known that NO, which is produced by 419 
the resident and infiltrating ovarian MO, and also by ovarian cells (Bukulmez & Arici 2000, Wu et 420 
al. 2004, 2007), stimulates cyclooxygenase-2 (COX-2) activity, which is the rate-limiting step in 421 
prostaglandin synthesis (Chandrasekharan & Simmons 2004). Therefore, the fact that iNOS protein 422 
expression and nitrite levels follow a similar pattern than the PGE2 content, suggests that PGE2 423 
synthesis can be modify by PCO MO secretions. 424 
The exact role of prostaglandins during apoptosis remains unclear. On the other hand, PGE2 425 
promotes survival of pathological cells by inhibiting apoptosis (Sheng et al. 1998, Rask et al. 2006), 426 
as well as death cells by a pro-apoptotic effects (Bowolaksono et al. 2008). We have observed an 427 
inverse relationship between PGE2 content and apoptosis of the PCO ovary after stimulation with 428 
PCO MO secretions, where a lower ovarian PGE2 content and release, and a higher apoptotic nuclei 429 
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numbers, were found compared with the effect induced by control MO secretions. It is also known 430 
that PGE2 suppress cell death induced by TNFα in ovarian bovine luteal cells (Bowolaksono et al. 431 
2008), and Kunisch et al. (2009) have shown that PGE2 can act as a negative feedback molecule in 432 
the signalling pathway linking TNFα to pro-destructive matrix metalloproteinase (MMP1) 433 
production in fibroblasts cells. In addition, a high ovarian matrix metalloproteinase-2 (MMP2) has 434 
been found to be increased in PCO rats compared with healthy controls (Rezvanfar et al. 435 
2014). Therefore, since from our previous results we know that the TNFα level of PCO MO 436 
secretions is higher than control MO secretions (Figueroa et al. 2012), it is conceivable that the low 437 
PGE2 content of PCO ovary stimulated with those secretions can contribute to apoptosis promotion. 438 
Moreover, an apoptotic role of androgen has been recognized in reproductive tissues. In this sense, 439 
global knockout of the androgen receptor in female mice leads to reduced fertility, with reduced 440 
numbers of antral follicles and increased granulose cells apoptosis (Shiina et al. 2006, Walters et al. 441 
2008, Tyndall et al. 2012). We have previously shown that PCO MO secretions decrease the 442 
conversion of androstenedione to estradiol in the PCO ovary, leading to an increase of 443 
androstenedione (Figueroa et al. 2012). This was also observed in the current study when PCO 444 
ovarian cells were incubated with PCO MO secretions, where an increase of androstenedione release 445 
from interstitial cells and a decrease of estradiol release from granulosa cells occurred. This effect 446 
can be attributed, at least in part, to the high TNFα content of PCO MO secretions. It has been 447 
reporter that TNFα activates transcription of an inducible repressor form of 3',5'-cyclic adenosine 5'-448 
monophosphate-responsive element binding modulator, and represses P450 aromatase in ovarian rat 449 
granulosa cells (Morales et al. 2006). In addition, we have previously observed an increase of IL6 450 
mRNA expression in PCO MO, compared with control MO, which was even greater after treatment 451 
with testosterone (Figueroa et al. 2012), indicating that IL6 mRNA abundance seems to be 452 
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modulated, as it was observed with TNFα, by testosterone environment. Since an enhanced IL6 453 
production may attenuate estradiol production, partially by inhibiting the expression of aromatase 454 
mRNA in rat granulosa cells (Tamura et al. 2000), it is possible that the increased IL6 expression of 455 
PCO MO may contribute to the steroidogenic ability of the MO secretions to decrease the 456 
androstenedione conversion to estradiol in the PCO ovary.   457 
Moreover, the low PGE2 content and NO production found in the PCO ovaries stimulated with MO 458 
secretions could contribute to the androgen environment. PGE2 stimulates Cyp19 expression, the 459 
key gene of estrogen biosynthesis, in rat granulosa cells (Cai et al. 2007). In relation to NO, it is 460 
known that the in vitro synthesis of estradiol is inversely regulated by NO in ovarian rat cells (Dave 461 
et al. 1997) and also in human granulosa-luteal cells cultures, being the NO capable of directly 462 
inhibiting the activity of aromatase or indirectly decreasing the levels of the mRNA of the enzyme 463 
(Snyder et al. 1996).   464 
Considering the present results and knowing that testosterone stimulates the TNFα and IL6 465 
production by MO, it is reasonable to suggest that the increase of androgens stimulated in ovarian 466 
cells by PCO MO secretions could in turn stimulate the cytokine production from MO, thus 467 
maintaining an apoptotic vicious cycle in the PCO ovary. 468 
Despite the bidirectional relationship between pro-inflammatory cytokines and the androgen excess 469 
in PCOS is still unclear, our results suggest that the detrimental effect of up- regulation of 470 
proinflammatory cytokines of spleen macrophages, could contribute to explain the lack or loss of 471 
reproductive capacities observed in the PCOS. Also, the possibility that MO secretions released into 472 
the general circulation can act on hypothalamic-pituitary sites, and subsequently produce changes in 473 
the ovary, cannot be discard. 474 
 475 
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Legends 
Figure 1A  
Macrophage secretions on the ovarian Bax mRNA expression. Ovaries from control (C) and 
polycystic (PCO) rats were stimulated with either basal medium (basal) or culture medium of 
C and PCO macrophages (macrophage secretions) for three hours. Target mRNA was 
normalized by the level of GAPDH mRNA. Values are mean ± S.E.M. of three independent 
experiments, each experiment performed with three C and three PCO rats. ***P<0.001 
compared with respective control.  
Figure 1B 
Macrophage secretions on the ovarian Bcl2 mRNA expression. Ovaries from control (C) and 
polycystic (PCO) rats were stimulated with either basal medium (basal) or culture medium of 
C and PCO macrophages (macrophage secretions) for three hours. Target mRNA was 
normalized by the level of GAPDH mRNA. Values are mean ± S.E.M. of three independent 
experiments, each experiment performed with three C and three PCO rats. ** P<0.01; * 
P<0.05 compared with respective control. 
Figure 1C 
Macrophage secretions on the ovarian NFkB mRNA expression. Ovaries from control (C) 
and polycystic (PCO) rats were stimulated with either basal medium (basal) or culture 
medium of C and PCO macrophages (macrophage secretions) for three hours. Target mRNA 
was normalized by the level of GAPDH mRNA. Values are mean ± S.E.M. of three 
independent experiments, each experiment performed with three C and three PCO rats. ** 
P<0.01; * P<0.05 compared with respective control. 
Figure 2A 
Macrophage secretions on the ovarian prostaglandin E2 (PGE2) content. Ovaries from control 
(C) and polycystic (PCO) rats were stimulated with either basal medium (basal) or culture 
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medium of C and PCO macrophages (macrophage secretions) for three hours. Values are 
mean ± S.E.M. of three independent experiments, each experiment performed with three C 
and three PCO rats. ***P<0.001 compared with respective control. 
Figure 2B 
Macrophage secretions on the ovarian prostaglandin E2 (PGE2) release. Ovaries from control 
(C) and polycystic (PCO) rats were stimulated with either basal medium (basal) or culture 
medium of C and PCO macrophages (macrophage secretions) for three hours. Values are 
mean ± S.E.M. of three independent experiments, each experiment performed with three C 
and three PCO rats. ***P<0.001; *P<0.05 compared with respective control. 
Figure 3A 
Macrophage secretions on the ovarian nitrite release. Ovaries from control (C) and polycystic 
(PCO) rats were stimulated with either basal medium (basal) or culture medium of C and 
PCO macrophages (macrophage secretions) for three hours. Values are mean ± S.E.M. of 
three independent experiments, each experiment performed with three C and three PCO rats. 
***P<0.001; **P<0.01 compared with respective control. 
Figure 3B 
Macrophage secretions on the ovarian iNOS protein expression. Ovaries from control (C) and 
polycystic (PCO) rats were stimulated with either basal medium (basal) or culture medium of 
C and PCO macrophages (macrophage secretions) for three hours. The corresponding graph 
shows integrated optical density of the bands. Values are mean ± S.E.M. of three independent 
experiments, each experiment performed with three C and three PCO rats. ***P<0.001; 
*P<0.05 compared with respective control.  
Figure 4A 
Effect of macrophage secretions on the androstenedione release from ovarian cells. Interstitial 
cells (IC) from control (C) and polycystic (PCO) rats were stimulated with either basal 
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medium (basal) or culture medium of C and PCO macrophages (macrophage secretions) for 
24 h. Values are mean ± S.E.M. of three independent experiments, each experiment 
performed with three C and three PCO rats. **P<0.01; * P<0.05 compared with respective 
control. 
Figure 4B 
Effect of macrophage secretions on the estradiol release from ovarian cells. Granulosa cells 
(GC) from control (C) and polycystic (PCO) rats were stimulated with either basal medium 
(basal) or culture medium of C and PCO macrophages (macrophage secretions) for 24 h. 
Values are mean ± S.E.M. of three independent experiments, each experiment performed 
with three C and three PCO rats. **P<0.01; *P<0.05 compared with respective control. 
Figure 5 
In-situ detection of apoptosis by TUNEL in ovarian sections of control and PCO rats. 
Representative photomicrographs of control (A, C and D) and estradiol valerate exposed (B, 
E, and F) rat ovary sections are shown. Ovaries from control and PCO rats were incubated for 
6h in basal medium (Basal) or macrophage secretions from control (MO Control) and PCO 
(MO PCO) rats. Nuclear dark brown staining shows a positive reaction. Arrowheads indicate 
isolated apoptotic cells and arrows indicate apoptotic follicles. In basal conditions, increased 
apoptosis on PCO ovary is evident as compared to negligible apoptosis in control ovary 
(figure A-B). PCO MO secretions increase TUNEL reactivity in control ovary and even more 
in PCO ovary (figure E-F). Control MO secretions do not modify TUNEL reactivity in 
control or PCO ovary compared to respective basal (figure C-D).TUNEL staining was 
predominately localized in granulosa cells. Magnification X100.  
Table 1  
In situ detection of apoptosis by TUNEL in ovarian sections from control and PCO rats 
treated, or untreated, with macrophages secretions.  
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Adult cycling Holtzman control and PCO rats (injected with 2 mg of estradiol valerate) were 
sacrificed at estrus day. Ovaries from control and PCO rats were incubated for 6 h in basal 
medium (Basal) and macrophage secretions from PCO rats (MO PCO). Then, the ovaries 
were collected and processed for detection of apoptosis by TUNEL. Intensity of the positive 
TUNEL reaction: (-) negative; (+/-) weak positive; (+) positive; (++) strong positive; (+++) 
strong positive including theca and stromal cells; Ab, absence of respective type of follicle. 
 
Legend to Supplementary Figure 1: 
Giemsa staining of the adhered macrophage cells, after incubation of the splenic cells in 
RPMI media for 2 h, at 37 °C in 95% air-5% CO2. The morphology was determined by light 
microscopy, and the percentage of macrophage cells was obtained on 500 total cells counted 
in different microscopic fields taken at random. Magnification x400. 
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Figure 5  
In-situ detection of apoptosis by TUNEL in ovarian sections of control and PCO rats. Representative 
photomicrographs of control (A, C and D) and estradiol valerate exposed (B, E, and F) rat ovary sections are 
shown. Ovaries from control and PCO rats were incubated for 6h in basal medium (Basal) or macrophage 
secretions from control (MO Control) and PCO (MO PCO) rats. Nuclear dark brown staining shows a positive 
reaction. Arrowheads indicate isolated apoptotic cells and arrows indicate apoptotic follicles. In basal 
conditions, increased apoptosis on PCO ovary is evident as compared to negligible apoptosis in control ovary 
(figure A-B). PCO MO secretions increase TUNEL reactivity in control ovary and even more in PCO ovary 
(figure E-F). Control MO secretions do not modify TUNEL reactivity in control or PCO ovary compared to 
respective basal (figure C-D).TUNEL staining was predominately localized in granulosa cells. Magnification 
X100.  
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Table 1. In situ detection of apoptosis by TUNEL in ovarian sections from control and 
PCO rats treated, or untreated, with macrophages secretions. 
 
GROUP 
 
                                          Follicles 
Primary            Secondary             Antral               Cystic 
 
Control (Basal) 
 
PCO (Basal) 
 
-                       -                           +/-                    Ab 
 
       +                        + +                       + +                   + +  
 
Control + MO PCO 
 
PCO + MO PCO 
 
-                       +                         + +                   Ab 
  
     + +                     + + +                   + + +                 + + + 
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